Auro Laboratories' Stock Reaches All-Time High, Outperforms Sector and Sensex
Auro Laboratories, a microcap pharmaceutical company, has seen a significant increase in its share price, reaching an all-time high of Rs. 270 on May 3rd, 2024. According to MarketsMojo, the stock call for Auro Laboratories is 'Hold', indicating positive performance but not the best time to buy or sell. The stock has outperformed its sector by 6.55% today and has been on a consecutive gain streak for the last 5 days. Auro Laboratories is also trading higher than its moving averages and has shown an impressive 321.57% increase in the last year, highlighting its strong performance and potential for growth in the pharmaceutical industry.
Auro Laboratories, a microcap pharmaceutical company, has been making waves in the stock market as its share price reached an all-time high of Rs. 270 on May 3rd, 2024. This significant increase in price has caught the attention of investors and analysts alike.
According to MarketsMOJO, a leading stock market analysis platform, the stock call for Auro Laboratories is 'Hold'. This suggests that while the company's performance is positive, it may not be the best time to buy or sell the stock.
In terms of price performance, Auro Laboratories has outperformed its sector by 6.55% today. The stock has been on a consecutive gain streak for the last 5 days, with a remarkable 34.7% increase in returns during this period. It also opened with a gap up of 6.55% today and touched an intraday high of Rs. 270.
The stock has been consistently trading at Rs. 270 since its opening, indicating a strong hold in the market. Auro Laboratories is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive sign for investors.
In terms of overall performance, Auro Laboratories has shown an impressive 321.57% increase in the last year, while the Sensex has only seen a 22.68% increase. This further highlights the company's strong performance and potential for growth.
With its recent surge in share price and positive performance, Auro Laboratories is definitely a company to watch out for in the pharmaceutical industry. However, it is important to note that this article is based on factual information and does not offer any recommendations or predictions for the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
